[PDF] Top 20 Product quality and compliance in the pharmaceutical industry

... for the release of the product to clients/ clinical trials. The product only can be released after a proper review of the batch documentation (production and packaging ... See full document

... reinforced the need to demonstrate and communicate value beyond what was initially standard, based on the “orthodox” clinical development program and taking the classical “physicians ... See full document

... On the contrary, a number of scholars have argued that gender difference is noteworthy since it has contributed to disparate behaviours and attitudes between male and female with effects on sale ... See full document

... than the increase in insurance covered costs) (Deloitte, 2018), is the main challenge faced by patients in this country, particularly to low income ...year in the United States ... See full document

... evaluates the total factor productivity change of a DMU between two periods ...[17-19]. The concept of productivity usually referred to labor productivity, this concept is very much related to TFP, defined ... See full document

... eng. Quality management system) postao je dominantan model menadžmenta kvaliteta u primeni, što se danas manifestuje brojem od 1150000 sertifikata za ovaj model širom ... See full document

... recognised the importance of information. Indeed, it is one of the most important assets of any ...involve the use of information in some ...from the information resource if the ... See full document

... of the most ancient and popular natural gums and can be obtained from the stem and branches of Acacia ...abundant in central Sudan, central and west Africa, tropical ... See full document

... that industry had in 2005 are still present today and mentioned four key problems often seen in QRM process that obstruct its purpose as “Lack of good science, too little rigor in risk ... See full document

... offers the proper tools in order to reduce the waste inside and between the different processes while being able to increase the value of the product (Karam, Liviu, ... See full document

... Research and development (R&D) in the pharmaceutical industry is an expensive activity and therefore, to be encouraged, requires barriers to en- try that guarantee that ... See full document

... flexibility in pharmaceutical industry refers to the ability of the organization to adapt to changing situations, reflected, for instance, in the level of rigidity of ... See full document

... protection and the firm providing it is a monopolist. The firm has the ability to set the price, p, of its ...that in many countries pharmaceutical prices are regulated, ... See full document

... manufacturers and market generic and in- licensed pharmaceutical products within three core ...business. The operations span 49 countries and focus on key therapeutic areas such ... See full document

... as the main source of economic growth, defining it as the changes in the methods itself (it can be either in production, transportation or anything involved to any part of the ... See full document

... interviews and surveys, focus groups or case studies, are extremely important to collect our customers’ opinion (how we do it? why we do it? how efficient were we in supporting their needs? what can we do ... See full document

... Within the scope of the of RDI project’s management, my experience in the process of ideas evaluation was very important to realize how the growth of a company can be sustained through ... See full document

... collected and analyzed information on the importance of drug packaging quality to end users and pharmaceutical industry, as an indicator of the process of traceability ... See full document

... interpreting the physic of phenomena of damage. On the other side, Failure Reporting, Analysis, Corrective Action System (FRACAS) and Failure Mode and Effect Analysis (FMEA) are irreplaceable ... See full document

... & and marketing activities in the endeavour to bring new products to global markets and materialize them ...enables pharmaceutical compa- nies to generate new development circles ... See full document